Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

The rheumatoid arthritis susceptibility polymorphism PTPN22 C1858T is not associated with leflunomide response or toxicity.

Hopkins AM, O'Doherty CE, Foster DJ, Suppiah V, Upton RN, Spargo LD, Cleland LG, Proudman SM, Wiese MD.

J Clin Pharm Ther. 2014 Oct;39(5):555-60. doi: 10.1111/jcpt.12189. Epub 2014 Jul 8.

PMID:
25040563
2.

The +1858C/T PTPN22 gene polymorphism confers genetic susceptibility to rheumatoid arthritis in Mexican population from the Western Mexico.

Torres-Carrillo NM, Ruiz-Noa Y, Martínez-Bonilla GE, Leyva-Torres SD, Torres-Carrillo N, Palafox-Sánchez CA, Navarro-Hernández RE, Rangel-Villalobos H, Oregón-Romero E, Muñoz-Valle JF.

Immunol Lett. 2012 Sep;147(1-2):41-6. doi: 10.1016/j.imlet.2012.05.007. Epub 2012 Jun 26.

PMID:
22743847
3.

Protein tyrosine phosphatase non-receptor type 22 (PTPN22) +1858 C>T gene polymorphism in Egyptian cases with rheumatoid arthritis.

Salama A, Elshazli R, Elsaid A, Settin A.

Cell Immunol. 2014 Jul;290(1):62-5. doi: 10.1016/j.cellimm.2014.05.003. Epub 2014 May 17.

PMID:
24880676
4.

The functional PTPN22 C1858T polymorphism confers risk for rheumatoid arthritis in patients from Central Mexico.

Rincón JF, Cano DL, Morales SJ, Jiménez ML, Cobos RE, Bello JR.

Clin Rheumatol. 2016 Jun;35(6):1457-62. doi: 10.1007/s10067-016-3223-z. Epub 2016 Mar 7.

PMID:
26951256
5.

Association of the PTPN22 gene polymorphism with autoantibody positivity in Turkish rheumatoid arthritis patients.

Ates A, Karaaslan Y, Karatayli E, Ertuğrul E, Aksaray S, Türkyilmaz A, Ozet G.

Tissue Antigens. 2011 Jul;78(1):56-9. doi: 10.1111/j.1399-0039.2011.01675.x. Epub 2011 Apr 21.

PMID:
21506938
6.

The PTPN22 C1858T polymorphism and rheumatoid arthritis: a meta-analysis.

Song GG, Bae SC, Kim JH, Lee YH.

Rheumatol Int. 2013 Aug;33(8):1991-9. doi: 10.1007/s00296-013-2679-2. Epub 2013 Jan 31.

PMID:
23370857
7.

The association between the PTPN22 C1858T polymorphism and rheumatoid arthritis: a meta-analysis update.

Lee YH, Bae SC, Choi SJ, Ji JD, Song GG.

Mol Biol Rep. 2012 Apr;39(4):3453-60. doi: 10.1007/s11033-011-1117-3. Epub 2011 Jun 26.

PMID:
21706348
8.

Meta-analysis reveals PTPN22 1858C/T polymorphism confers susceptibility to rheumatoid arthritis in Caucasian but not in Asian population.

Nabi G, Akhter N, Wahid M, Bhatia K, Mandal RK, Dar SA, Jawed A, Haque S.

Autoimmunity. 2016;49(3):197-210. doi: 10.3109/08916934.2015.1134514. Epub 2016 Jan 13.

PMID:
26763276
9.

Association of PTPN22 rs2476601 and STAT4 rs7574865 polymorphisms with rheumatoid arthritis: A meta-analysis update.

Elshazli R, Settin A.

Immunobiology. 2015 Aug;220(8):1012-24. doi: 10.1016/j.imbio.2015.04.003. Epub 2015 Apr 28.

PMID:
25963842
10.

Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations.

van Oene M, Wintle RF, Liu X, Yazdanpanah M, Gu X, Newman B, Kwan A, Johnson B, Owen J, Greer W, Mosher D, Maksymowych W, Keystone E, Rubin LA, Amos CI, Siminovitch KA.

Arthritis Rheum. 2005 Jul;52(7):1993-8.

11.

The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population.

Chabchoub G, Teixiera EP, Maalej A, Ben Hamad M, Bahloul Z, Cornelis F, Ayadi H.

Ann Hum Biol. 2009 May-Jun;36(3):342-9. doi: 10.1080/03014460902817968.

PMID:
19343596
12.

Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis.

Wiese MD, Schnabl M, O'Doherty C, Spargo LD, Sorich MJ, Cleland LG, Proudman SM.

Arthritis Res Ther. 2012 Jul 12;14(4):R163. doi: 10.1186/ar3911.

13.

[PTPN22 1858C/T polymorphism is associated with rheumatoid arthritis susceptibility in Caucasian population: a meta-analysis].

Tang GP, Hu L, Zhang QH.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2014 Jul;43(4):466-73. Chinese.

PMID:
25187463
14.

Genetic polymorphism of CYP1A2 but not total or free teriflunomide concentrations is associated with leflunomide cessation in rheumatoid arthritis.

Hopkins AM, Wiese MD, Proudman SM, O'Doherty CE, Upton RN, Foster DJ.

Br J Clin Pharmacol. 2016 Jan;81(1):113-23. doi: 10.1111/bcp.12760. Epub 2015 Oct 28.

15.

Association of the PTPN22 gene (-1123G > C) polymorphism with rheumatoid arthritis in Chinese patients.

Feng X, Li YZ, Zhang Y, Bao SM, Tong DW, Zhang SL, Hu CJ.

Tissue Antigens. 2010 Oct;76(4):297-300. doi: 10.1111/j.1399-0039.2010.01521.x.

PMID:
20604892
16.

Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients.

Harrison P, Pointon JJ, Farrar C, Brown MA, Wordsworth BP.

Rheumatology (Oxford). 2006 Aug;45(8):1009-11. Epub 2006 Feb 20.

PMID:
16490755
17.

Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis.

Goldenberg MM.

Clin Ther. 1999 Nov;21(11):1837-52; discussion 1821. Review.

PMID:
10890256
18.

Association of PTPN22 single nucleotide polymorphism with rheumatoid arthritis but not with allergic asthma.

Majorczyk E, Jasek M, Płoski R, Wagner M, Kosior A, Pawlik A, Obojski A, Luszczek W, Nowak I, Wiśniewski A, Kuśnierczyk P.

Eur J Hum Genet. 2007 Oct;15(10):1043-8. Epub 2007 Jun 20.

19.

PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis.

Totaro MC, Tolusso B, Napolioni V, Faustini F, Canestri S, Mannocci A, Gremese E, Bosello SL, Alivernini S, Ferraccioli G.

PLoS One. 2011;6(9):e24292. doi: 10.1371/journal.pone.0024292. Epub 2011 Sep 16.

20.

The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden.

Kokkonen H, Johansson M, Innala L, Jidell E, Rantapää-Dahlqvist S.

Arthritis Res Ther. 2007;9(3):R56. Erratum in: Arthritis Res Ther. 2007;9(5):403.

Supplemental Content

Support Center